{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:57:10Z","timestamp":1793699830436,"version":"4.5.1"},"reference-count":51,"publisher":"Rockefeller University Press","issue":"4","license":[{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":264,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,6]]},"abstract":"<jats:p>Tumor-specific mutations can generate neoantigens that drive CD8 T cell responses against cancer. Next-generation sequencing and computational methods have been successfully applied to identify mutations and predict neoantigens. However, only a small fraction of predicted neoantigens are immunogenic. Currently, predicted peptide binding affinity for MHC-I is often the major criterion for prioritizing neoantigens, although little progress has been made toward understanding the precise functional relationship between affinity and immunogenicity. We therefore systematically assessed the immunogenicity of peptides containing single amino acid mutations in mouse tumor models and divided them into two classes of immunogenic mutations. The first comprises mutations at a nonanchor residue, for which we find that the predicted absolute binding affinity is predictive of immunogenicity. The second involves mutations at an anchor residue; here, predicted relative affinity (compared with the WT counterpart) is a better predictor. Incorporating these features into an immunogenicity model significantly improves neoantigen ranking. Importantly, these properties of neoantigens are also predictive in human datasets, suggesting that they can be used to prioritize neoantigens for individualized neoantigen-specific immunotherapies.<\/jats:p>","DOI":"10.1084\/jem.20190179","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T14:39:28Z","timestamp":1579099168000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":107,"title":["Mutation position is an important determinant for predicting cancer neoantigens"],"prefix":"10.1084","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-3867","authenticated-orcid":true,"given":"Aude-H\u00e9l\u00e8ne","family":"Capietto","sequence":"first","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchit","family":"Jhunjhunwala","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5879-0525","authenticated-orcid":true,"given":"Samuel B.","family":"Pollock","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lupardus","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9597-5537","authenticated-orcid":true,"given":"Jim","family":"Wong","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5708-9366","authenticated-orcid":true,"given":"Lena","family":"H\u00e4nsch","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cevallos","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Chestnut","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6057-3765","authenticated-orcid":true,"given":"Ajay","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lounsbury","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9973-8272","authenticated-orcid":true,"given":"Tamaki","family":"Nozawa","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Fan","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile C.","family":"de la Cruz","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-4567","authenticated-orcid":true,"given":"Qui T.","family":"Phung","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Taraborrelli","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0074-0020","authenticated-orcid":true,"given":"Benjamin","family":"Haley","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie R.","family":"Lill","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6132-7299","authenticated-orcid":true,"given":"Ira","family":"Mellman","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5890-4374","authenticated-orcid":true,"given":"Richard","family":"Bourgon","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9122-5181","authenticated-orcid":true,"given":"L\u00e9lia","family":"Delamarre","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2020,1,15]]},"reference":[{"key":"2023072610033171300_bib1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2017.02.007","article-title":"Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction","volume":"46","author":"Abelin","year":"2017","journal-title":"Immunity."},{"key":"2023072610033171300_bib2","first-page":"512","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume-title":"Nature.","author":"Balachandran","year":"2017"},{"key":"2023072610033171300_bib3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw"},{"key":"2023072610033171300_bib4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2014.03.047","article-title":"Deconstructing the peptide-MHC specificity of T cell recognition","volume":"157","author":"Birnbaum","year":"2014","journal-title":"Cell."},{"key":"2023072610033171300_bib5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PLOS Comput. Biol."},{"key":"2023072610033171300_bib6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41419-018-0301-y","article-title":"CRISPR whole-genome screening identifies new necroptosis regulators and RIPK1 alternative splicing","volume":"9","author":"Callow","year":"2018","journal-title":"Cell Death Dis."},{"key":"2023072610033171300_bib7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.coi.2017.04.007","article-title":"Characterizing neoantigens for personalized cancer immunotherapy","volume":"46","author":"Capietto","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"2023072610033171300_bib8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1126\/science.aaa3828","article-title":"Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Science."},{"key":"2023072610033171300_bib9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1074\/mcp.TIR117.000383","article-title":"High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferon\u03b3-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome","volume":"17","author":"Chong","year":"2018","journal-title":"Mol. Cell. Proteomics."},{"key":"2023072610033171300_bib10","doi-asserted-by":"publisher","first-page":"E1754","DOI":"10.1073\/pnas.1500973112","article-title":"TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes","volume":"112","author":"Chowell","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072610033171300_bib11","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1172\/JCI82416","article-title":"Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes","volume":"125","author":"Cohen","year":"2015","journal-title":"J. Clin. Invest."},{"key":"2023072610033171300_bib12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat. Genet."},{"key":"2023072610033171300_bib13","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1084\/jem.20141308","article-title":"Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity","volume":"211","author":"Duan","year":"2014","journal-title":"J. Exp. Med."},{"key":"2023072610033171300_bib14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129152","article-title":"Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection","volume":"5","author":"Ebrahimi-Nik","year":"2019","journal-title":"JCI Insight."},{"key":"2023072610033171300_bib15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2326-6066.CIR-13-0227","article-title":"HLA-binding properties of tumor neoepitopes in humans","volume":"2","author":"Fritsch","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"2023072610033171300_bib16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/annonc\/mdx687","article-title":"Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma","volume":"29","author":"Ghorani","year":"2018","journal-title":"Ann. Oncol."},{"key":"2023072610033171300_bib17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature22976","article-title":"Identifying specificity groups in the T cell receptor repertoire","volume":"547","author":"Glanville","year":"2017","journal-title":"Nature."},{"key":"2023072610033171300_bib18","unstructured":"Gordon, M., and T.Lumley. 2017. forestplot: Advanced forest plot using \u2018grid\u2019 graphics. R package version 1.7.2. https:\/\/CRAN.R-project.org\/package=forestplot"},{"key":"2023072610033171300_bib19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature."},{"key":"2023072610033171300_bib20","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/eji.201141774","article-title":"Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity","volume":"42","author":"Harndahl","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"2023072610033171300_bib22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ccell.2018.03.018","article-title":"Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer","volume":"33","author":"Hellmann","year":"2018","journal-title":"Cancer Cell."},{"key":"2023072610033171300_bib24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/imm.12160","article-title":"NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery","volume":"141","author":"J\u00f8rgensen","year":"2014","journal-title":"Immunology."},{"key":"2023072610033171300_bib25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature."},{"key":"2023072610033171300_bib26","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2023072610033171300_bib27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature24473","article-title":"A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy","volume":"551","author":"\u0141uksza","year":"2017","journal-title":"Nature."},{"key":"2023072610033171300_bib28","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science."},{"key":"2023072610033171300_bib29","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","article-title":"Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor","volume":"26","author":"McLaren","year":"2010","journal-title":"Bioinformatics."},{"key":"2023072610033171300_bib30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1158\/2326-6066.CIR-16-0019","article-title":"Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade","volume":"5","author":"Nathanson","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"2023072610033171300_bib31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.immuni.2014.12.022","article-title":"T cell receptor cross-reactivity between similar foreign and self peptides influences naive cell population size and autoimmunity","volume":"42","author":"Nelson","year":"2015","journal-title":"Immunity."},{"key":"2023072610033171300_bib32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.32614\/RJ-2015-001","article-title":"Peptides: A package for data mining of antimicrobial peptides","volume":"7","author":"Osorio","year":"2015","journal-title":"R J."},{"key":"2023072610033171300_bib33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature."},{"key":"2023072610033171300_bib34","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.4049\/jimmunol.1600582","article-title":"Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity","volume":"197","author":"Rasmussen","year":"2016","journal-title":"J. Immunol."},{"key":"2023072610033171300_bib35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/2326-6066.CIR-17-0559","article-title":"Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer","volume":"6","author":"Rech","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"2023072610033171300_bib36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science."},{"key":"2023072610033171300_bib37","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1002\/eji.201343324","article-title":"Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation","volume":"43","author":"Rosalia","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"2023072610033171300_bib38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature."},{"key":"2023072610033171300_bib39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4049\/jimmunol.165.1.25","article-title":"T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity","volume":"165","author":"Sandberg","year":"2000","journal-title":"J. Immunol."},{"key":"2023072610033171300_bib40","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201600061","article-title":"Building proteomic tool boxes to monitor MHC class I and class II peptides","volume":"17","author":"Schumacher","year":"2017","journal-title":"Proteomics."},{"key":"2023072610033171300_bib41","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0161-5890(94)90019-1","article-title":"Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays","volume":"31","author":"Sette","year":"1994","journal-title":"Mol. Immunol."},{"key":"2023072610033171300_bib42","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.153.12.5586","article-title":"The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes","volume":"153","author":"Sette","year":"1994","journal-title":"J. Immunol."},{"key":"2023072610033171300_bib43","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","article-title":"ROCR: visualizing classifier performance in R","volume":"21","author":"Sing","year":"2005","journal-title":"Bioinformatics."},{"key":"2023072610033171300_bib44","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2023072610033171300_bib45","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.aaf2288","article-title":"Targeting of cancer neoantigens with donor-derived T cell receptor repertoires","volume":"352","author":"Str\u00f8nen","year":"2016","journal-title":"Science."},{"key":"2023072610033171300_bib46","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"2023072610033171300_bib47","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science."},{"key":"2023072610033171300_bib48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science."},{"key":"2023072610033171300_bib49","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.4049\/jimmunol.156.9.3308","article-title":"Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability","volume":"156","author":"van der Burg","year":"1996","journal-title":"J. Immunol."},{"key":"2023072610033171300_bib50","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/bioinformatics\/btq057","article-title":"Fast and SNP-tolerant detection of complex variants and splicing in short reads","volume":"26","author":"Wu","year":"2010","journal-title":"Bioinformatics."},{"key":"2023072610033171300_bib51","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature."},{"key":"2023072610033171300_bib52","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.immuni.2015.05.001","article-title":"Clonal Deletion Prunes but Does Not Eliminate Self-Specific \u03b1\u03b2 CD8(+) T Lymphocytes","volume":"42","author":"Yu","year":"2015","journal-title":"Immunity."},{"key":"2023072610033171300_bib53","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41591-018-0040-8","article-title":"Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer","volume":"24","author":"Zacharakis","year":"2018","journal-title":"Nat. Med."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20190179\/1766879\/jem_20190179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20190179\/1766879\/jem_20190179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T10:05:06Z","timestamp":1690365906000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/217\/4\/e20190179\/133605\/Mutation-position-is-an-important-determinant-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,6]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20190179","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,15]]},"article-number":"e20190179"}}